MOTS-c
A mitochondrial-derived “exercise mimetic” — promising and clinically advancing, but still emerging.
Verdict — C · Emerging / Mixed
Genuinely interesting mechanism with clinical momentum, but the human evidence and verified supply aren’t there yet. Emerging — for the experienced only.
Overview
MOTS-c is a mitochondrial-derived peptide that activates AMPK and acts as a metabolic “exercise mimetic,” with longevity and insulin-sensitivity interest. Clinical development is advancing, but human evidence and clean sourcing are still emerging.
PepScore Breakdown — the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version? — our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.
Best-Sourced Vendor
Limitless Life Nootropics
Vendor 84 · AStrong vendor grade (A) and the best verified supply right now for MOTS-c — batch-matched independent COA freshness 50%.
Visit Limitless Life Nootropics ↗Ranked by Source Match = Vendor Grade × batch-COA freshness. Affiliate status is never an input to any grade, and a paying vendor never outranks a non-paying one on a tie.How this works →
Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.